Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.

Colorectal cancer highlights from ASCO 2025 include findings from the BREAKWATER, ATOMIC, DYNAMIC-III, and TRIPLETE trials.

Adding polatuzumab vedotin (Polivy) to standard-of-care treatment significantly improved overall survival (OS) in patients ...

The biopharma company—whose US headquarters is in Atlanta—will be building a new biologics manufacturing facility in a city ...

The Inflation Reduction Act (IRA), signed into law in August 2022, marked a historic shift in US healthcare policy by ...

The global Western Blotting Market is estimated to be valued at USD 909.5 million in 2025 and is projected to reach USD 1,567.9 million by 2035, registering a compound annual growth rate (CAGR) of 5.6 ...

The global Nucleic Acid Isolation and Purification Market was valued at USD 902.9 million in 2020 and is projected to reach USD 1,174.1 million by 2025. From 2025 to 2035, the market is forecast to ...

The global Allantoin Extract for Skincare Products Market is poised for remarkable growth, projected to increase from an ...